medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Alcov: Estimating Variant of Concern
Abundance from SARS-CoV-2 Wastewater
Sequencing Data
Isaac Ellmen1,2*, Michael D.J. Lynch1,2, Delaney Nash1,2, Jiujun Cheng1,2, Jozef I. Nissimov1,
Trevor C. Charles1,2
1

Department of Biology, University of Waterloo, Waterloo, ON, Canada
Metagenom Bio Life Science Inc., Waterloo, ON, Canada

2

*corresponding author email: isaac.ellmen@uwaterloo.ca

Abstract
Detection of SARS-CoV-2 in wastewater is an important strategy for community level
surveillance. Variants of concern (VOCs) can be detected in the wastewater samples using
next generation sequencing, however it can be challenging to determine the relative
abundance of different VOCs since the reads cannot be assembled into complete genomes.
Here, we present Alcov (abundance learning of SARS-CoV-2 variants), a tool that uses
mutation frequencies in SARS-CoV-2 sequencing data to predict the distribution of VOC
lineages in the sample. We used Alcov to predict the distributions of lineages from three
wastewater samples which agreed well with clinical data. By predicting not just which VOCs
are present, but their relative abundances in the population, Alcov extracts a more complete
snapshot of the variants which are circulating in a community.

Introduction
The COVID-19 pandemic caused by the SARS-CoV-2 virus is responsible for millions of
deaths worldwide. Monitoring the composition of SARS-CoV-2 lineages which are
circulating in a region is crucial to managing the pandemic. Detecting variants of concern
(VOCs) can help inform epidemiological models, as some VOCs have increased
transmissibility and immune escape [1]. A useful approach in tracking these variants is
monitoring SARS-CoV-2 in wastewater. Since viral particles are shed in stool, collecting and
analyzing wastewater from wastewater treatment plants provides a snapshot of the viral
composition for an entire community [2].
A sample of SARS-CoV-2 can be tested for VOCs using next generation sequencing. Clinical
samples may be sequenced and aligned to a reference genome to determine which mutations
are present. These signature mutations can be used to identify which lineage, and so VOC, a
sample
contains.
However,
sequencing
wastewater
samples
is should
morenot
complicated
for
twopractice.
NOTE: This
preprint reports
new research
that has not been
certified by peer
review and
be used to guide
clinical

1

medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

reasons. First, the samples usually contain multiple lineages (and possibly multiple VOCs)
and so the consensus sequence can not provide an accurate snapshot of the composition of the
sample. Second, wastewater samples often contain low-quality RNA which may lead to
significant gaps in the sequenced genome of the virus. Thus, only relying on a small number
of unique signature mutations may be an unreliable method for identifying variants of
concern if these mutations are not covered in the sample.
Here we present Alcov (abundance learning of SARS-CoV-2 variants), a tool for calling
VOCs in a mixed sample and estimating their relative abundance within that sample using a
large number of mutations distributed across the SARS-CoV-2 genome. This allows for the
estimation of VOC abundance within a community using only sequenced wastewater instead
of a massive sequencing program of infected individuals.

Methods
Preprocessing the reads
Alcov receives a BAM file of filtered reads, aligned to the SARS-CoV-2 reference genome,
NC_045512.2 [3]. In all of our experiments we preprocessed the reads using SeqPrep [4] to
quality filter and merge paired reads if required. Next we aligned the reads to the reference
genome using BWA [5] and used samtools [6] to sort the reads and save the file as a BAM.
Converting amino acid mutations to nucleotide polymorphisms
Since many repositories of common SARS-CoV-2 mutations such as covariants
(https://covariants.org/) and outbreak.info [7] (https://outbreak.info/) refer to mutations by
their amino acid change on the gene, rather than nucleotide change on the genome, we first
implemented a function to convert between the two. Briefly, to convert from a nucleotide to
an amino acid change, the program finds the gene and codon for that location and returns the
wildtype and mutated amino acids at that location. To convert from an amino acid change to a
nucleotide change, the tool finds the amino acid and determines which single nucleotide
polymorphism could account for it.
Determining mutation frequencies
To determine the frequency of a given mutation, Alcov scans the reads at each index using
pysam [8] and calculates the frequency as the number of single-nucleotide variants over the
number of reads which cover that base. In order to reduce the variance of the estimates,
Alcov only considers locations with coverage of at least 40 reads. There are however cases
where there are multiple nucleotide polymorphisms that can account for the same amino acid
change, such as alternate codons or codon deletions. In such cases, Alcov assigns the
mutation‚Äôs prevalence as the highest nucleotide polymorphism frequency from the set.

2

medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Lineage abundance estimation as an optimization problem
After calculating the frequency of each mutation, the problem is to determine a relative
abundance for each VOC lineage that could collectively account for the observed mutation
frequencies. Let ùë¶ùëñ denote the frequency of mutation ùëñ and ùë•ùëñ,ùëó denote whether lineage ùëó
contains mutation ùëñ. Finally, let Œ≤ùëó denote the predicted relative abundance of lineage ùëó in the
sample. Then the predicted frequency of mutation ùëñ is:
Œ£ùëóŒ≤ùëóùë•ùëñ,ùëó
We can cast the problem of determining the lineages as determining a set of Œ≤ùëó to minimize
the total difference between the observed mutation rates and the predicted mutation rates:
Œ£ùëñ|ùë¶ùëñ ‚àí Œ£ Œ≤ùëóùë•ùëñ,ùëó|
ùëó

Or, similarly, the squares of the differences:
2

Œ£ùëñ(ùë¶ùëñ ‚àí Œ£ Œ≤ùëóùë•ùëñ,ùëó)
ùëó

This formulation is a well studied problem in statistics known as ordinary least squares (OLS)
which can be solved efficiently in closed form [9]. We implemented the model using
scikit-learn version 0.24 [10] which allows for the additional constraint that all Œ≤ùëó must be
positive. While there is no explicit condition that Œ£ùëóŒ≤ùëó ‚â§ 1, in most cases the best fit will be a
reasonable estimation of abundances.
It is worth noting that this formulation addresses both of the major problems with wastewater
sequencing. First, it seeks to solve the problem of determining the composition of lineages in
the sample and so explicitly assumes that the reads are coming from a mixed sample. Second,
it is resilient to dropout of mutations (e.g., due to sample degradation or unequal coverage).
By considering each mutation as a data point in the linear regression, it can easily consider
only and all mutations with sufficient read coverage.

Results
Data collection
In order to test the predictions made by Alcov, we searched for ‚ÄúSARS-CoV-2 wastewater‚Äù
on the Sequencing Read Archive (SRA) (https://www.ncbi.nlm.nih.gov/sra). Seven SRA
studies were found, of which three had sufficient data to make predictions. One recent sample
from each study was downloaded and preprocessed using the steps described above before
3

medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

being passed into Alcov for VOC abundance prediction. The specific samples used were
SAMN18310570, SAMN18378816, and SAMN18915228. These samples were each
analyzed as a case study. The VOC mutation information Alcov uses was downloaded from
https://outbreak.info/compare-lineages on May 12, 2021.
Frankfurt, Germany - December 2020 (SAMN18310570)
The first sample analyzed was collected from Frankfurt in December 2020 [11]. This sample
acted as a negative control since there were not widespread VOCs in Germany at that time.
As expected, Alcov predicts negligible abundances for all of the variants of concern (Figure
1). The slightly non-zero values are likely due to sequencing/reverse transcription errors, or
low levels of sequence variation within that community.
New York City, New York, USA - March 2021 (SAMN18378816)
The second sample analyzed was collected in New York City (NYC) in March 2021 [12].
Only a 332-nucleotide region of the receptor binding domain was sequenced which covered
six known mutations present in VOCs (S:L452R, S:S477N, S:T478K, S:E484K/Q, and
S:N501Y). Because multiple VOCs were identical with respect to these mutations, some were
merged before making the prediction. Two VOCs were predicted by Alcov in this sample,
both of which are consistent with clinical data [7]. B.1.1.7 was predicted to account for 43%
of the sample whereas some mixture of B.1.526.1, B.1.427, and B.1.429 was predicted to
account for 22% of the sample (Figure 2). It is very likely that the latter portion was due to
B.1.526.1, which is a strain that originated in NYC and has been observed in high prevalence
in NYC clinical samples [7]. Similarly, the B.1.1.7 proportion is in line with clinical sampling
data.
Newport, Oregon, USA - March 2021 (SAMN18915228)
The third sample analyzed was collected in Newport in March 2021. The sample had many
regions with low coverage which made it challenging to analyze by looking at only the most
common characteristic mutations. [tool name] predicted a split between 62% B.1.417/B.1.429
and 38% B.1.351 (Figure 3). The B.1.417/B.1.429 prediction makes sense since these VOCs
originate from California which is adjacent to Oregon and are present in clinical samples
from Lincoln county which includes Newport [7]. The B.1.351 prediction is surprising since
it is rare in Oregon and, to our knowledge, has not been discovered in Lincoln. Mutations
which were not included in the prediction due to insufficient read depth were analyzed
manually, and supported the B.1.351 prediction. This example may demonstrate some of the
utility of Alcov for wastewater identifying VOCs that have yet to be captured in clinical
sequencing. That said, it is unlikely that the proportions in this sample are representative of
the larger community, and may have been exaggerated due to stochasticity in PCR
amplification.

4

medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Discussion
By estimating the abundance of VOCs from single wastewater sequencing runs, Alcov
enables genomic epidemiology of SARS-CoV-2 variants without the need for a large number
of clinical sequences. Thus, sequencing and analyzing wastewater samples is a cost-effective
and rapid solution for determining the composition of variants in both large and small
communities. Additionally, since clinical samples are typically only sequenced after testing
positive for other diagnostics such as PCR tests, this may be a less biased population analysis.
It is important to note that Alcov can only determine the composition of RNA reads which
are sequenced. This composition may differ from the actual distribution of virus lineages in a
population due to increased shedding, differential PCR amplification of some amplicons,
differential RNA stability in wastewater, or other factors. Determining the correlation
between the wastewater abundances and clinical samples will be an important avenue for
future research. Another limitation is the limited lineage information which is included. Since
Alcov only looks for VOCs, it may attribute the presence of mutations from non-VOC
lineages to VOCs. This could be addressed by also including the specific lineages which are
circulating in the community which is being sampled (as determined by clinical sequencing
data). Finally, it is worth noting that the approach taken by Alcov is not specific to
SARS-CoV-2. The tool could be adapted to monitor future pandemics, or even plant viruses
in hydroponic systems.

Availability
Alcov is written in Python and can be used as a command line interface. It has been tested on
macOS and is available for download at https://github.com/Ellmen/alcov.

Acknowledgments
This work was supported by Mitacs Accelerate Fellowships (IT18981) to IE and DN, through
funding held by JIN.

5

medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

References
1. Nelson G, Buzko O, Spilman P, Niazi K, Rabizadeh S, Soon-Shiong P. Molecular dynamic
simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination
of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change
greater than N501Y mutant alone, potentially resulting in an escape mutant. preprint.
Biophysics; 2021. doi:10.1101/2021.01.13.426558.
2. Gupta S, Parker J, Smits S, Underwood J, Dolwani S. Persistent viral shedding of
SARS‚ÄêCoV‚Äê2 in faeces ‚Äì a rapid review. Colorectal Dis. 2020;22:611‚Äì20.
3. Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. A new coronavirus associated
with human respiratory disease in China. Nature. 2020;579:265‚Äì9.
4. St. John J. jstjohn/SeqPrep. C. 2021. https://github.com/jstjohn/SeqPrep. Accessed 22
May 2021.
5. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform.
Bioinforma Oxf Engl. 2009;25:1754‚Äì60.
6. Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of
SAMtools and BCFtools. GigaScience. 2021;10. doi:10.1093/gigascience/giab008.
7. Julia L. Mullen, Ginger Tsueng, Alaa Abdel Latif, Manar Alkuzweny, Marco Cano, Emily
Haag, et al. outbreak.info. outbreak.info. https://outbreak.info/. Accessed 30 May 2021.
8. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence
Alignment/Map format and SAMtools. Bioinforma Oxf Engl. 2009;25:2078‚Äì9.
9. Rencher AC, Christensen WF. Methods of multivariate analysis. Third Edition. Hoboken,
New Jersey: Wiley; 2012.
10. Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn:
Machine Learning in Python. J Mach Learn Res. 2011;12:2825‚Äì30.
11. Agrawal S, Orschler L, Lackner S. Metatranscriptomic Analysis Reveals SARS-CoV-2
Mutations in Wastewater of the Frankfurt Metropolitan Area in Southern Germany. Microbiol
Resour Announc. 2021;10.
12. Smyth DS, Trujillo M, Cheung K, Gao A, Hoxie I, Kannoly S, et al. Detection of Mutations
Associated with Variants of Concern Via High Throughput Sequencing of SARS-CoV-2
Isolated from NYC Wastewater. medRxiv. 2021;:2021.03.21.21253978.

6

medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figures

Figure 1 - Predicted lineages in Frankfurt (December 2020). Lineages are coloured according
to their predicted frequency which is also labeled. As expected, the frequency of each VOC
lineage is negligible.

7

medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure 2 - Predicted lineages in NYC (March 2021). Because of limited sequencing coverage,
some VOCs were indistinguishable and so automatically merged. The B.1.1.7 and B.1.526.1
predictions agree with clinical data.

8

medRxiv preprint doi: https://doi.org/10.1101/2021.06.03.21258306; this version posted June 6, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-ND 4.0 International license .

Figure 3 - Predicted lineages in Newport (March 2021). The B.1.427/9 lineages originated in
California which is adjacent to Oregon. The B.1.351 prediction is high compared to clinical
data but is well supported across multiple mutations in the sample.

9

